FTC Can Seek Disgorgement In Cephalon Suit, Judge Says
The Federal Trade Commission can pursue billions of dollars Cephalon Inc. allegedly made through a series of pay-for-delay deals meant to stave off competition with its blockbuster narcolepsy drug, a Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article